These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 31907000)
1. A call for consensus in defining efficacy in clinical trials for opioid addiction: combined results from a systematic review and qualitative study in patients receiving pharmacological assisted therapy for opioid use disorder. Dennis BB; Sanger N; Bawor M; Naji L; Plater C; Worster A; Woo J; Bhalerao A; Baptist-Mohseni N; Hillmer A; Rice D; Corace K; Hutton B; Tugwell P; Thabane L; Samaan Z Trials; 2020 Jan; 21(1):30. PubMed ID: 31907000 [TBL] [Abstract][Full Text] [Related]
2. The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol. Dennis BB; Naji L; Bawor M; Bonner A; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; Samaan Z; Thabane L Syst Rev; 2014 Sep; 3():105. PubMed ID: 25239213 [TBL] [Abstract][Full Text] [Related]
3. Opioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteria. Dennis BB; Roshanov PS; Naji L; Bawor M; Paul J; Plater C; Pare G; Worster A; Varenbut M; Daiter J; Marsh DC; Desai D; Samaan Z; Thabane L Trials; 2015 Oct; 16():475. PubMed ID: 26489415 [TBL] [Abstract][Full Text] [Related]
4. Identifying patient-important outcomes in medication-assisted treatment for opioid use disorder patients: a systematic review protocol. Sanger N; Shahid H; Dennis BB; Hudson J; Marsh D; Sanger S; Worster A; Teed R; Rieb L; Tugwell P; Hutton B; Shea B; Beaton D; Corace K; Rice D; Maxwell L; Samaan MC; de Souza RJ; Thabane L; Samaan Z BMJ Open; 2018 Dec; 8(12):e025059. PubMed ID: 30518592 [TBL] [Abstract][Full Text] [Related]
5. Assessing fragility of statistically significant findings from randomized controlled trials assessing pharmacological therapies for opioid use disorders: a systematic review. Naji L; Dennis B; Rodrigues M; Bawor M; Hillmer A; Chawar C; Deck E; Worster A; Paul J; Thabane L; Samaan Z Trials; 2024 Apr; 25(1):286. PubMed ID: 38678289 [TBL] [Abstract][Full Text] [Related]
6. Statement of the American Society Of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction. Kraus ML; Alford DP; Kotz MM; Levounis P; Mandell TW; Meyer M; Salsitz EA; Wetterau N; Wyatt SA; J Addict Med; 2011 Dec; 5(4):254-63. PubMed ID: 22042215 [TBL] [Abstract][Full Text] [Related]
7. Pain and Opioid Addiction: A Systematic Review and Evaluation of Pain Measurement in Patients with Opioid Dependence on Methadone Maintenance Treatment. Dennis BB; Bawor M; Paul J; Plater C; Pare G; Worster A; Varenbut M; Daiter J; Marsh DC; Desai D; Thabane L; Samaan Z Curr Drug Abuse Rev; 2016; 9(1):49-60. PubMed ID: 27021147 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance Treatment. Dennis BB; Roshanov PS; Bawor M; Paul J; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; Thabane L; Samaan Z Pain Physician; 2016 Jan; 19(1):E181-95. PubMed ID: 26752486 [TBL] [Abstract][Full Text] [Related]
9. Methadone at tapered doses for the management of opioid withdrawal. Amato L; Davoli M; Ferri M; Ali R Cochrane Database Syst Rev; 2004 Oct; (4):CD003409. PubMed ID: 15495052 [TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy of Opioid Addiction: "Putting a Real Face on a False Demon". Salsitz E; Wiegand T J Med Toxicol; 2016 Mar; 12(1):58-63. PubMed ID: 26567033 [TBL] [Abstract][Full Text] [Related]
11. The impact of chronic pain on opioid addiction treatment: a systematic review protocol. Dennis BB; Bawor M; Paul J; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; Thabane L; Samaan Z Syst Rev; 2015 Apr; 4():49. PubMed ID: 25927914 [TBL] [Abstract][Full Text] [Related]
12. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail. Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100 [TBL] [Abstract][Full Text] [Related]
13. A systematic review of sex differences in treatment outcomes among people with opioid use disorder receiving buprenorphine maintenance versus other treatment conditions. Ling S; Mangaoil R; Cleverley K; Sproule B; Puts M Drug Alcohol Depend; 2019 Apr; 197():168-182. PubMed ID: 30831429 [TBL] [Abstract][Full Text] [Related]
14. Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis. Yarborough BJ; Stumbo SP; McCarty D; Mertens J; Weisner C; Green CA Drug Alcohol Depend; 2016 Mar; 160():112-8. PubMed ID: 26796596 [TBL] [Abstract][Full Text] [Related]
15. Readiness and recovery: Transferring between methadone and buprenorphine/naloxone for the treatment of opioid use disorder. Bishop B; Gilmour J; Deering D Int J Ment Health Nurs; 2019 Feb; 28(1):226-236. PubMed ID: 30019812 [TBL] [Abstract][Full Text] [Related]
16. Methadone at tapered doses for the management of opioid withdrawal. Amato L; Davoli M; Ferri M; Ali R Cochrane Database Syst Rev; 2002; (2):CD003409. PubMed ID: 12076479 [TBL] [Abstract][Full Text] [Related]
17. Methadone at tapered doses for the management of opioid withdrawal. Amato L; Davoli M; Ferri M; Ali R Cochrane Database Syst Rev; 2003; (3):CD003409. PubMed ID: 12917966 [TBL] [Abstract][Full Text] [Related]
18. Slow-release oral morphine as maintenance therapy for opioid dependence. Ferri M; Minozzi S; Bo A; Amato L Cochrane Database Syst Rev; 2013 Jun; (6):CD009879. PubMed ID: 23740540 [TBL] [Abstract][Full Text] [Related]
19. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care. Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238 [TBL] [Abstract][Full Text] [Related]
20. Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: A systematic review. Maglione MA; Raaen L; Chen C; Azhar G; Shahidinia N; Shen M; Maksabedian E; Shanman RM; Newberry S; Hempel S J Subst Abuse Treat; 2018 Jun; 89():28-51. PubMed ID: 29706172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]